|
[1]
|
Dunn, B.E., Cohen, H. and Blaser, M.J. (1997) Helicobacter pylori. Clinical Microbiology Reviews, 10, 720-741. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Li, Y., Choi, H., Leung, K., Jiang, F., Graham, D.Y. and Leung, W.K. (2023) Global Prevalence of Helicobacter pylori Infection between 1980 and 2022: A Systematic Review and Meta-Analysis. The Lancet Gastroenterology & Hepatology, 8, 553-564. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Lanas, A. and Chan, F.K.L. (2017) Peptic Ulcer Disease. The Lancet, 390, 613-624. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Wotherspoon, A.C. (1998) Gastric Lymphoma of Mucosa-Associated Lymphoid Tissue and Helicobacter pylori. Annual Review of Medicine, 49, 289-299. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Crabtree, J.E., Shallcross, T.M., Heatley, R.V. and Wyatt, J.I. (1991) Mucosal Tumour Necrosis Factor Alpha and Interleukin-6 in Patients with Helicobacter pylori Associated Gastritis. Gut, 32, 1473-1477. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Rizwan, M., Alvi, A. and Ahmed, N. (2008) Novel Protein Antigen (JHP940) from the Genomic Plasticity Region of Helicobacter pylori Induces Tumor Necrosis Factor Alpha and Interleukin-8 Secretion by Human Macrophages. Journal of Bacteriology, 190, 1146-1151. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Lin, Q., Xu, H., Chen, X., Tang, G., Gu, L. and Wang, Y. (2015) Helicobacter pylori Cytotoxin-Associated Gene a Activates Tumor Necrosis Factor-α and Interleukin-6 in Gastric Epithelial Cells through P300/CBP-Associated Factor-Mediated Nuclear Factor-κB P65 Acetylation. Molecular Medicine Reports, 12, 6337-6345. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Moon, S., Park, Y., Jang, S., Kim, S., Song, D., Shin, D., et al. (2024) Interleukin-2 Improves Insulin Sensitivity through Hypothalamic Sympathetic Activation in Obese Mice. Journal of Neuroinflammation, 21, Article No. 250. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Imai, Y., Dobrian, A.D., Weaver, J.R., Butcher, M.J., Cole, B.K., Galkina, E.V., et al. (2013) Interaction between Cytokines and Inflammatory Cells in Islet Dysfunction, Insulin Resistance and Vascular Disease. Diabetes, Obesity and Metabolism, 15, 117-129. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Russo, B., Menduni, M., Borboni, P., Picconi, F. and Frontoni, S. (2021) Autonomic Nervous System in Obesity and Insulin-Resistance—The Complex Interplay between Leptin and Central Nervous System. International Journal of Molecular Sciences, 22, Article 5187. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Könner, A.C. and Brüning, J.C. (2012) Selective Insulin and Leptin Resistance in Metabolic Disorders. Cell Metabolism, 16, 144-152. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Yun, J. and Ko, S. (2021) Current Trends in Epidemiology of Cardiovascular Disease and Cardiovascular Risk Management in Type 2 Diabetes. Metabolism, 123, Article 154838. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Bielka, W., Przezak, A., Molęda, P., Pius-Sadowska, E. and Machaliński, B. (2024) Double Diabetes—When Type 1 Diabetes Meets Type 2 Diabetes: Definition, Pathogenesis and Recognition. Cardiovascular Diabetology, 23, Article No. 62. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Suzuki, M., Kanazawa, A., Shiba, M., Kojima, H. and Harano, Y. (2000) Insulin Resistance in Diabetic Microangiopathies. Journal of Diabetes and Its Complications, 14, 40-45. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Placzkowska, S., Pawlik-Sobecka, L., Kokot, I. and Piwowar, A. (2019) Indirect Insulin Resistance Detection: Current Clinical Trends and Laboratory Limitations. Biomedical Papers, 163, 187-199. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Li, Y., You, A., Tomlinson, B., Yue, L., Zhao, K., Fan, H., et al. (2021) Insulin Resistance Surrogates Predict Hypertension Plus Hyperuricemia. Journal of Diabetes Investigation, 12, 2046-2053. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Malek, M., Khamseh, M.E., Chehrehgosha, H., Nobarani, S. and Alaei-Shahmiri, F. (2021) Triglyceride Glucose-Waist to Height Ratio: A Novel and Effective Marker for Identifying Hepatic Steatosis in Individuals with Type 2 Diabetes Mellitus. Endocrine, 74, 538-545. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Wallace, T.M., Levy, J.C. and Matthews, D.R. (2004) Use and Abuse of HOMA Modeling. Diabetes Care, 27, 1487-1495. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Huang, J., Liu, Z., Ma, J., Liu, J., Lv, M., Wang, F., et al. (2022) The Association between Helicobacter pylori Seropositivity and Bone Mineral Density in Adults. Mediators of Inflammation, 2022, 1-7. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Huang, J., Zhang, K., Wang, F. and Tang, X. (2023) The Associations between Helicobacter pylori Immunoglobulin G Seropositivity and Body Mass Index in Adults. BMC Infectious Diseases, 23, Article No. 485. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Chen, Y., Yang, C., You, N. and Zhang, J. (2023) Relationship between Helicobacter pylori and Glycated Hemoglobin: A Cohort Study. Frontiers in Cellular and Infection Microbiology, 13, Article 1196338. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Zhu, X., Xiong, Y., Meng, X., Xu, H., Huo, L. and Deng, W. (2024) Association of Triglyceride-Glucose Index with Helicobacter pylori Infection and Mortality among the US Population. Diabetology & Metabolic Syndrome, 16, Article No. 187. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Park, S.H., Jeon, W.K., Kim, S.H., et al. (2005) Helicobacter pylori Eradication Has No Effect on Metabolic and Inflammatory Parameters. Journal of the National Medical Association, 97, 508-513.
|
|
[24]
|
Chen, L., Chien, C., Lin, C. and Chien, R. (2021) Increased Glycated Hemoglobin but Decreased Cholesterol after a Loss of Helicobacter pylori Infection: A Community-Based Longitudinal Metabolic Parameters Follow-Up Study. Journal of Personalized Medicine, 11, Article 997. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W. and Xu, H. (2022) Trends in Insulin Resistance: Insights into Mechanisms and Therapeutic Strategy. Signal Transduction and Targeted Therapy, 7, Article No. 216. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Bretto, E., Frara, S., Armandi, A., Caviglia, G.P., Saracco, G.M., Bugianesi, E., et al. (2024) Helicobacter pylori in Inflammatory Bowel Diseases: Active Protagonist or Innocent Bystander? Antibiotics, 13, Article 267. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Ji, R., Zuo, X., Yu, T., Gu, X., Li, Z., Zhou, C., et al. (2012) Mucosal Barrier Defects in Gastric Intestinal Metaplasia: In Vivo Evaluation by Confocal Endomicroscopy. Gastrointestinal Endoscopy, 75, 980-987. [Google Scholar] [CrossRef] [PubMed]
|